Venous Malformations: Classification, Development, Diagnosis, and Interventional Radiologic Management

Radiologic Clinics of North America

Volumn 46, Issue 3, 2008, Pages 545-597

  Legiehn, Gerald M ^a   Heran, Manraj K S ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Classification; Embolization; Hemangioma; Radiology; Sclerotherapy; Vascular malformation; Venous malformation

Indexed keywords

ALCOHOL; MONOETHANOLAMINE OLEATE; POLIDOCANOL; TECHNETIUM 99M; TETRADECYL SULFATE SODIUM; ZEIN;

ANAPHYLAXIS; ANGIOGENESIS; ANGIOGRAPHY; ANGIOOSTEOHYPERTROPHY SYNDROME; AUTOSOMAL DOMINANT INHERITANCE; BLISTER; BLUE RUBBER BLEB NEVUS SYNDROME; BOCKENHEIMER; BRADYCARDIA; CARDIOPULMONARY ARREST; CELL INTERACTION; CLASSIFICATION; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DEEP VEIN THROMBOSIS; DEVELOPMENT; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIRECT PERCUTANEOUS PHLEBOGRAPHY; DISSEMINATED INTRAVASCULAR CLOTTING; ECHOGRAPHY; EMBRYOLOGY; ENDOTHELIUM; ERYTHEMA; EYE DISEASE; FAMILIAL CUTANEOMUCOSAL VENOUS MALFORMATION; FOLLOW UP; GORHAM STOUT; HEMANGIOMA; HEMOLYSIS; HUMAN; HYPERPIGMENTATION; HYPOTENSION; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTERVENTIONAL RADIOLOGY; LUNG EMBOLISM; MICROSCOPY; MOLECULAR GENETICS; MORPHOGENESIS; MUSCLE CONTRACTURE; NECROSIS; NEPHROTOXICITY; NERVE INJURY; NONSURGICAL INVASIVE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; OSTEOCHONDROMA; OSTEOLYSIS; PAIN; PATHOPHYSIOLOGY; PATIENT CARE; PERICYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEUS; RADIODIAGNOSIS; RADIOGRAPHY; REVIEW; SCLEROTHERAPY; SKIN ULCER; SURGICAL TECHNIQUE; SWELLING; THERAPY EFFECT; THROMBOPHLEBITIS; TREATMENT INDICATION; TREATMENT OUTCOME; VARICOSIS; VEIN DISEASE; VEIN MALFORMATION;

ADULT; ALGORITHMS; ANGIOGRAPHY; CHILD; EMBOLIZATION, THERAPEUTIC; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; RADIOGRAPHY, INTERVENTIONAL; SCLEROTHERAPY; VASCULAR MALFORMATIONS; VEINS;

EID: 49149095888     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2008.02.008     Document Type: Review

References (199)

1. Vikkula M., Boon L.M., and Mulliken J.B. Molecular genetics of vascular malformations. Matrix Biol 20 5-6 (2001) 327-335
2. Eifert S., Villavicencio J.L., Kao T.C., et al. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg 31 3 (2000) 462-471
3. Puig S., Casati B., Staudenherz A., et al. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 53 1 (2005) 35-45
4. Boon L.M., Mulliken J.B., Vikkula M., et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 3 9 (1994) 1583-1587
5. Vikkula M., Boon L.M., and Mulliken J.B. Molecular basis of vascular anomalies. Trends Cardiovasc Med 8 (1998) 218-292
6. Brouillard P., and Vikkula M. Vascular malformations: localized defects in vascular morphogenesis. Clin Genet 63 (2003) 340-351
7. Dowd CF, Cullen SP, Hoffman WY, et al. Radiographic misdiagnosis confounds evaluation of vascular anomalies. Paper presented at: 15th Congress of the International Society for the Study of Vascular Anomalies. Wellington, New Zealand, February 22-25, 2004.
8. Wu JK, Lane TS, Roberts CT, et al. Accuracy in terminology, diagnosis and management for referrals to a vascular anomalies center. Paper presented at: 15th Congress of the International Society for the Study of Vascular Anomalies. Wellington, New Zealand, February 22-25, 2004.
9. Legiehn G.M., and Heran M.K. Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin North Am 37 3 (2006) 435-474 vii-viii
10. Marler J.J., and Mulliken J.B. Vascular anomalies: classification, diagnosis, and natural history. Facial Plast Surg Clin North Am 9 4 (2001) 495-504
11. Tasnadi G. Epidemiology and etiology of congenital vascular malformations. Semin Vasc Surg 6 4 (1993) 200-203
12. Nagy M., and Brodsky L. Multidisciplinary approach to management of hemangiomas and vascular malformations. Facial Plast Surg Clin North Am 9 4 (2001) 551-559
13. Hein K.D., Mulliken J.B., Kozakewich H.P., et al. Venous malformations of skeletal muscle. Plast Reconstr Surg 110 7 (2002) 1625-1635
14. Lee B.B., and Bergan J.J. Advanced management of congenital vascular malformations: a multidisciplinary approach. Cardiovasc Surg 10 6 (2002) 523-533
15. Mulliken J.B., and Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69 (1982) 412-420
16. Fishman S.J., and Mulliken J.B. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am 40 6 (1993) 1177-1200
17. Virchow R. Angiome. In: Virchow R. (Ed). Die krankhaften geschwulste vol. 3 (1863), August Hirschwald, Berlin 306-325
18. Wegener G. Ueber lymphangiome. Arch Klin Chir 20 (1877) 641-707
19. DeTakats G. Vascular anomalies of the extremities. Report of five cases. Surg Gynecol Obstet 55 (1932) 227-237
20. Watson W.L. Blood and lymph vessel tumors: a report of 1,056 cases. Surg Gynecol Obstet 71 (1940) 569-588
21. Belov S. Anatomopathological classification of congenital vascular defects. Semin Vasc Surg 6 (1993) 219-224
22. Malan E. Malformations (angiodysplasias) (1974), Carlo Erba Foundation, Milan (Italy)
23. Degni M., Gerson L., Ishikawa K., et al. Classification of the vascular diseases of the limbs. J Cardiovasc Surg (Torino) 14 (1973) 109-116
24. Degni M., Gerson L., Ishikava K., et al. Classification of vascular diseases of the limbs. Minerva Cardioangiol 21 2 (1973) 162-167 [in Italian]
25. Burrows P.E., Muliken J.B., Fellows K.E., et al. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol 141 (1983) 483-488
26. Belov S. Classification, terminology and nosology of congenital vascular defects. In: Belov S., Loose D.A., and Weber J. (Eds). Vascular malformations. Proceedings of the 7th Meeting of the International Workshop on Vascular Malformations (1989), Einhorn-Presse Verlag, Reinbek (Germany) 25-28
27. Belov S. Classification of congenital vascular defects. Int Angiol 9 (1990) 141-146
28. Jackson I.T., Carreno R., Potparic Z., et al. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 91 (1993) 1216-1230
29. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangioma and vascular malformation. J Dermatol 24 (1997) 701-710
30. Garzon M.C., Huang J.T., Enjolras O., et al. Vascular malformations: part I. J Am Acad Dermatol 56 3 (2007) 353-370 [quiz: 371-4]
31. North P.E., and Mihm Jr. M.C. Histopathological diagnosis of infantile hemangiomas and vascular malformations. Facial Plast Surg Clin North Am 9 4 (2001) 505-524
32. Kilpatrick S.E. Diagnostic musculoskeletal surgical pathology: clinicoradiologic and cytologic correlations (2004), Saunders, Philadelphia
33. Mazoyer E., Enjolras O., Laurian C., et al. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol 24 4 (2002) 243-251
34. Clearkin K.P., and Enzinger F.M. Intravascular papillary endothelial hyperplasia. Arch Pathol Lab Med 100 8 (1976) 441-444
35. Mulliken J.B., Fishman S.J., and Burrows P.E. Vascular anomalies. Curr Probl Surg 37 (2000) 519-584
36. Vikkula M., Boon L.M., Carraway III K.L., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87 7 (1996) 1181-1190
37. Dubois J., Soulez G., Oliva V.L., et al. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 21 6 (2001) 1519-1531
38. North P.E., Waner M., Mizeracki A., et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31 1 (2000) 11-22
39. Adegboyega P.A., and Qiu S. Hemangioma versus vascular malformation: presence of nerve bundle is a diagnostic clue for vascular malformation. Arch Pathol Lab Med 129 6 (2005) 772-775
40. Kahn H.J., Bailey D., and Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 15 4 (2002) 434-440
41. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 46 4 (2005) 396-402
42. Galambos C., and Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol 8 2 (2005) 181-189
43. Debelenko L.V., Perez-Atayde A.R., Mulliken J.B., et al. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 18 11 (2005) 1454-1460
44. Tille J.C., and Pepper M.S. Hereditary vascular anomalies: new insights into their pathogenesis. Arterioscler Thromb Vasc Biol 24 9 (2004) 1578-1590
45. Moore K.L. The developing human (1982), Saunders, Philadelphia
46. Luttun A., Carmeliet G., and Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 12 2 (2002) 88-96
47. Risau W. Mechanisms of angiogenesis. Nature 386 6626 (1997) 671-674
48. Risau W., Sariola H., Zerwes H.G., et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102 3 (1988) 471-478
49. Boon L.M., Mulliken J.B., Enjolras O., et al. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol 140 8 (2004) 971-976
50. Gallione C.J., Pasyk K.A., Boon L.M., et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 32 3 (1995) 197-199
51. Zietz S., Happle R., Hohenleutner U., et al. The venous nevus: a distinct vascular malformation suggesting mosaicism. Dermatology 216 1 (2008) 31-36
52. Ramsauer M., and D'Amore P.A. Getting Tie(2)d up in angiogenesis. J Clin Invest 110 11 (2002) 1615-1617
53. Brouillard P., and Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet 16 Spec No. 2 (2007) R140-R149
54. Li L.Y., Barlow K.D., and Metheny-Barlow L.J. Angiopoietins and Tie2 in health and disease. Pediatr Endocrinol Rev 2 3 (2005) 399-408
55. Wang Q.K. Update on the molecular genetics of vascular anomalies. Lymphat Res Biol 3 4 (2005) 226-233
56. Loughna S., and Sato T.N. Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol 30 (2001) 319-325
57. Calvert J.T., Riney T.J., Kontos C.D., et al. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8 7 (1999) 1279-1289
58. Davis J., Aldrich T.H., Jones P.F., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression closing. Cell 87 (1996) 1161-1169
59. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
60. Sato T.N., Qin Y., Kozak C.A., et al. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A 90 20 (1993) 9355-9358
61. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74
62. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
63. Hellstrom M., Kalen M., Lindahl P., et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126 14 (1999) 3047-3055
64. Brouillard P., Boon L.M., Mulliken J.B., et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (glomangiomas). Am J Hum Genet 70 4 (2002) 866-874
65. Miettinen M., Paal E., Lasota J., et al. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol 26 3 (2002) 301-311
66. Miettinen M., Lehto V.P., and Virtanen I. Glomus tumor cells: evaluation of smooth muscle and endothelial cell properties. Virchows Arch B Cell Pathol Incl Mol Pathol 43 2 (1983) 139-149
67. Dervan P.A., Tobbia I.N., Casey M., et al. Glomus tumours: an immunohistochemical profile of 11 cases. Histopathology 14 5 (1989) 483-491
68. Chen Y.G., Liu F., and Massague J. Mechanism of TGFbeta receptor inhibition by FKBP12. EMBO J 16 13 (1997) 3866-3876
69. Tian X.L., Kadaba R., You S.A., et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427 6975 (2004) 640-645
70. Enjolras O., Ciabrini D., Mazoyer E., et al. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol 36 2 Pt 1 (1997) 219-225
71. Dubois J., and Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 29 (1999) 879-893
72. Abernethy L.J. Classification and imaging of vascular malformations in children. Eur Radiol 13 11 (2003) 2483-2497
73. Redondo P. Vascular malformations (I). Concept, classification, pathogenesis and clinical features. Actas Dermosifiliogr 98 3 (2007) 141-158 [in Spanish]
74. Nicolaides A.N., Breddin H.K., Carpenter P., et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol 24 1 (2005) 1-26
75. Klippel L.M., and Trenaunay P. Du naevus variqueux ostéohypertrophique. Archives générales de médecine (Paris) 185 (1900) 641-672
76. Maari C., and Frieden I.J. Klippel-Trenaunay syndrome: the importance of geographic stains in identifying lymphatic disease and risk of complications. J Am Acad Dermatol 51 3 (2004) 391-398
77. Muliken J.B., and Young A.E. Vascular birthmarks: hemangiomas and malformations (1988), WB Saunders, Philadelphia
78. Servelle M. Klippel and Trenaunay's syndrome: 768 operated cases. Ann Surg 201 3 (1985) 365-373
79. Gloviczki P., Hollier L.H., Telander R.L., et al. Surgical implications of Klippel-Trenaunay syndrome. Ann Surg 197 3 (1983) 353-362
80. Gloviczki P., Stanson A.W., Stickler G.B., et al. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 110 3 (1991) 469-479
81. Dogan R., Dogan O.F., Oc M., et al. A rare vascular malformation, Klippel-Trenaunay syndrome: report of a case with deep vein agenesis and review of the literature. J Cardiovasc Surg (Torino) 44 1 (2003) 95-100
82. Bean W.B. Blue rubber bleb nevi of the skin and gastrointestinal tract: vascular spiders and related lesions of the skin (1958), Charles Thomas, Springfield (IL) p. 178-85
83. Garzon M.C., Huang J.T., Enjolras O., et al. Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 56 4 (2007) 541-564
84. Redondo P. Vascular malformations (II). Diagnosis, pathology and treatment. Actas Dermosifiliogr 98 4 (2007) 219-235 [in Spanish]
85. Boyd J.B., Mulliken J.B., Kaban L.B., et al. Skeletal changes associated with vascular malformations. Plast Reconstr Surg 74 (1984) 789-797
86. Pearse H.E., and Morton J.J. The stimulation of bone growth by venous stasis. J Bone Joint Surg Am 12 (1930) 97-111
87. Bergula A.P., Huang W., and Frangos J.A. Femoral vein ligation increases bone mass in the hindlimb suspended rat. Bone 24 3 (1999) 171-177
88. de Greef C., Flandroy P., Mathurin P., et al. Low flow venous malformations in children. Phlebologie 45 4 (1992) 477-481 [in French]
89. Kanterman R.Y., Witt P.D., Hsieh P.S., et al. Klippel-Trenaunay syndrome: imaging findings and percutaneous intervention. AJR Am J Roentgenol 167 4 (1996) 989-995
90. Enjolras O., Wassef M., and Merland J.J. Maffucci syndrome: a false venous malformation? A case with hemangioendothelioma with fusiform cells. Ann Dermatol Venereol 125 8 (1998) 512-515 [in French]
91. Jackson J.B.S. A boneless arm. Boston Med Surg Journal 18 (1838) 368-369
92. Gorham L.W., and Stout A.P. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relation to hemangiomatosis. J Bone Joint Surg Am 37-A 5 (1955) 985-1004
93. Johnson P.M., and Mc C.J. Observations on massive osteolysis: a review of the literature and report of a case. Radiology 71 1 (1958) 28-42
94. Moller G., Priemel M., Amling M., et al. The Gorham-Stout syndrome (Gorham's massive osteolysis): a report of six cases with histopathological findings. J Bone Joint Surg Br 81 3 (1999) 501-506
95. Moller G., Gruber H., Priemel M., et al. Gorham-Stout idiopathic osteolysis: a local osteoclastic hyperactivity?. Pathologe 20 3 (1999) 177-182 [in German]
96. Paltiel H.J., Burrows P.E., Kozakewich H.P., et al. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 214 (2000) 747-754
97. Latifi H.R., and Siegel M.J. Color Doppler flow imaging of pediatric soft tissue masses. J Ultrasound Med 13 3 (1994) 165-169
98. Trop I., Dubois J., Guibaud L., et al. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology 212 (1999) 841-845
99. Sintzoff Jr. S.A., Gillard I., Van Gansbeke D., et al. Ultrasound evaluation of soft tissue tumors. J Belge Radiol 75 4 (1992) 276-280
100. Bastarrika G., Redondo P., Sierra A., et al. New techniques for the evaluation and therapeutic planning of patients with Klippel-Trenaunay syndrome. J Am Acad Dermatol 56 2 (2007) 242-249
101. Hyodoh H., Hori M., Akiba H., et al. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics 25 25 (2005) S159-S171
102. Konez O., and Burrows P.E. Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 10 2 (2002) 363-388 vii
103. Hayashi N., Masumoto T., Okubo T., et al. Hemangiomas in the face and extremities: MR-guided sclerotherapy: optimization with monitoring of signal intensity changes in vivo. Radiology 226 2 (2003) 567-572
104. Lewin J.S., Merkle E.M., Duerk J.L., et al. MR imaging-guided percutaneous sclerotherapy: preliminary experience with 14 procedures in three patients. Radiology 211 2 (1999) 566-570
105. Boll D.T., Merkle E.M., and Lewin J.S. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology 233 (2004) 376-384
106. Fayad L.M., Hazirolan T., Bluemke D., et al. Vascular malformations in the extremities: emphasis on MR imaging features that guide treatment options. Skeletal Radiol 35 3 (2006) 127-137
107. Vilanova J.C., Barceló J., Smirniotopoulos J.G., et al. Hemangioma from head to toe: MR imaging with pathologic correlation. Radiographics 24 (2004) 367-385
108. Meyer J.S., Hoffer F.A., Barnes P.D., et al. Biological classification of soft tissue vascular anomalies: MR correlation. AJR Am J Roentgenol 157 (1991) 559-564
109. Konez O. Vascular anomalies. emedicine.com. Modified March 23, 2007. Available at: (2008). www.emedicine.com/radio/topic896.htm Accessed May 13
110. Goyal M., Causer P.A., and Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 223 3 (2002) 639-644
111. Burrows P.E., Laor T., Paltiel H., et al. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 16 3 (1998) 455-488
112. Robertson R.L., Robson C.D., Barnes P.D., et al. Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am 9 1 (1999) 115-132
113. Kern S., Niemeyer C., Darge K., et al. Differentiation of vascular birthmarks by MR imaging. Acta Radiol 41 (2000) 453-457
114. van Rijswijk C.S., van der Linden E., van der Woude H.J., et al. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol 178 5 (2002) 1181-1187
115. Stepansky F., Hecht E.M., Rivera R., et al. Dynamic MR angiography of upper extremity vascular disease: pictorial review. Radiographics 28 1 (2008) e28
116. Polak J.F., and Fox L.A. MR assessment of the extremity veins. Semin Ultrasound CT MR 20 1 (1999) 36-46
117. Herborn C.U., Goyen M., Lauenstein T.C., et al. Comprehensive time-resolved MRI of peripheral vascular malformations. AJR Am J Roentgenol 181 3 (2003) 729-735
118. Ohgiya Y., Hashimoto T., Gokan T., et al. Dynamic MRI for distinguishing high-flow from low-flow peripheral vascular malformations. AJR Am J Roentgenol 185 5 (2005) 1131-1137
119. Korosec F.R., Frayne R., Grist T.M., et al. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 36 3 (1996) 345-351
120. O'Donovan J.C., Donaldson J.S., Morello F.P., et al. Symptomatic hemangiomas and venous malformations in infants, children and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol 169 3 (1997) 723-729
121. Lee B.B., Kim D.I., Huh S., et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 33 4 (2001) 764-772
122. Lee B.B., Kim Y.W., Seo J.M., et al. Current concepts in lymphatic malformation. Vasc Endovascular Surg 39 1 (2005) 67-81
123. Lee B.B. New approaches to the treatment of congenital vascular malformations (CMVs): a single centre experience. Eur J Vasc Endovasc Surg 30 2 (2005) 184-197
124. Lee B.B., Do Y.S., Byun H.S., et al. Advanced management of venous malformation with ethanol scherotherapy: mid-term results. J Vasc Surg 37 3 (2003) 533-538
125. Donnelly L.F., Adams D.M., and Bisset III G.S. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 174 3 (2000) 597-608
126. Buckmiller L.M. Update on hemangiomas and vascular malformations. Curr Opin Otolaryngol Head Neck Surg 12 6 (2004) 476-487
127. Rinker B., Karp N.S., Margiotta M., et al. The role of magnetic resonance imaging in the management of vascular malformations of the trunk and extremities. Plast Reconstr Surg 112 2 (2003) 504-510
128. Rautio R., Saarinen J., Laranne J., et al. Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment. Acta Radiol 45 4 (2004) 397-403
129. Villavicencio J.L. Primum non nocere: is it always true? The use of absolute ethanol in the management of congenital vascular malformations. J Vasc Surg 33 4 (2001) 904-906
130. Lee BB. New approach to the combined form of congenital vascular malformation: venolymphatic malformation. Presented at the Eastern Vascular Society 18th Annual Meeting. Pittsburgh (PA), May 5-7, 2005.
131. Puig S., Aref H., Chigot V., et al. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 33 2 (2003) 99-103
132. Upton J., Coombs C.J., Mulliken J.B., et al. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg [Am] 24 (1999) 1019-1035
133. Lee B.B., Do Y.S., Yakes W., et al. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 39 3 (2004) 590-600
134. Yakes W.F., Rossi P., and Odink H. How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol 19 2 (1996) 65-71
135. Do Y.S., Yakes W.F., Shin S.W., et al. Ethanol embolization of arteriovenous malformations: interim results. Radiology 235 2 (2005) 674-682
136. Choi Y.H., Han M.H., O-Ki K., et al. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 13 5 (2002) 475-482
137. de Lorimier A.A. Sclerotherapy for venous malformations. J Pediatr Surg 30 2 (1995) 188-193
138. Shin B.S., Do Y.S., Lee B.B., et al. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology 235 3 (2005) 1072-1077
139. Yakes W.F., Haas D.K., Parker S.H., et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 170 3 Pt 2 (1989) 1059-1066
140. Yakes W.F., Krauth L., Ecklung J., et al. Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery 40 6 (1997) 1145-1152
141. Tan K.T., Kirby J., Rajan D.K., et al. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol 18 3 (2007) 343-351
142. Mason K.P., Michna E., Zurakowski D., et al. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies. Radiology 217 1 (2000) 127-132
143. Yakes W.F., Luethke J.M., Parker S.H., et al. Ethanol embolization of vascular malformations. Radiographics 10 5 (1990) 787-796
144. Stefanutto T.B., and Halbach V. Bronchospasm precipitated by ethanol injection in arteriovenous malformation. AJNR Am J Neuroradiol 24 10 (2003) 2050-2051
145. Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg 80 2 (1995) 415-417
146. Yakes W.F., and Baker R. Cardiopulmonary collapse: sequelae of ethanol embolotherapy [abstract]. Radiology 189 P (1993) 145
147. Garel L., Mareschal J.L., Gagnadoux M.F., et al. Fatal outcome after ethanol renal ablation in child with end-stage kidneys. AJR Am J Roentgenol 146 (1986) 593-594
148. Siniluoto T.M., Svendsen P.A., Wikholm G.M., et al. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg 31 2 (1997) 145-150
149. Anavi Y., Har-El G., and Mintz S. The treatment of facial haemangioma by percutaneous injections of sodium tetradecyl sulfate. J Laryngol Otol 102 1 (1988) 87-90
150. Woods J.E. Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions. Plast Reconstr Surg 79 4 (1987) 542-549
151. Govrin-Yehudain J., Moscona A.R., Calderon N., et al. Treatment of hemangiomas by sclerosing agents: an experimental and clinical study. Ann Plast Surg 18 6 (1987) 465-469
152. Baurmash H., and DeChiara S. A conservative approach to the management of orofacial vascular lesions in infants and children: report of cases. J Oral Maxillofac Surg 49 11 (1991) 1222-1225
153. Cho K.J., Williams D.M., Brady T.M., et al. Transcatheter embolization with sodium tetradecyl sulfate: experimental and clinical results. Radiology 153 1 (1984) 95-99
154. Pascarella L., Bergan J.J., Yamada C., et al. Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg 19 (2005) 457-464
155. Guex J.J. Indications for the sclerosing agent polidocanol (aetoxisclerol dexo, aethoxisklerol kreussler). J Dermatol Surg Oncol 19 10 (1994) 959-961
156. Jain R., Bandhu S., Sawhney S., et al. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 30 7 (2002) 416-423
157. Mimura H., Kanazawa S., Yasui K., et al. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama 57 5 (2003) 227-234
158. Nitecki S., and Bass A. Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome. Isr Med Assoc J 9 2 (2007) 72-75
159. Cacciola E., Giustolisi R., Musso R., et al. Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: possible additional mechanism of adverse reaction during sclerotherapy. J Lab Clin Med 109 2 (1987) 225-226
160. Suzuki N., Nakao A., Nonami T., et al. Experimental study on the effects of sclerosants foresophageal varices on blood coagulation, fibrinolysis and systemic hemodynamics. Gastroenterol Jpn 27 3 (1992) 309-316
161. Cabrera J., Cabrera J.J., Garcia-Olmedo M.A., et al. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 139 11 (2003) 1409-1416
162. Yamaki T., Nozaki M., and Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26 4 (2000) 323-328
163. Marrocco-Trischitta M.M., Guerrini P., Abeni D., et al. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 28 2 (2002) 153-155
164. Ethamolin, clinical pharmacology. Available at:. http://www.rxlist.com/cgi/generic/ethamolin_cp.htm Accessed February 2, 2008
165. Johann A.C., Aguiar M.C., do Carmo M.A., et al. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 5 (2005) 579-584
166. Connor W.E., Hoak J.C., and Warner E.D. Massive thrombosis produced by fatty acid infusion. J Clin Invest 42 (1963) 860-866
167. Hyodoh H., Fujita A., Hyodoh K., et al. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy. Cardiovasc Intervent Radiol 24 5 (2001) 348-351
168. Mitsuzaki K., Yamashita Y., Utsunomiya D., et al. Balloon-occluded retrograde transvenous embolization of a pelvic arteriovenous malformation. Cardiovasc Intervent Radiol 22 6 (1999) 518-520
169. Gabal A.M. Percutaneous technique for sclerotherapy of vertebral hemangioma compressing spinal cord. Cardiovasc Intervent Radiol 25 6 (2002) 494-500
170. Matsumoto K., Nakanishi H., Koizumi Y., et al. Sclerotherapy of hemangioma with late involution. Dermatol Surg 29 6 (2003) 668-671 [discussion: 671]
171. Dubois J.M., Sebag G.H., De Prost Y., et al. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology 180 (1991) 195-198
172. Kauffmann G.W., Rassweiler J., Richter G., et al. Capillary embolization with Ethibloc: new embolization concept tested in dog kidneys. AJR Am J Roentgenol 137 6 (1981) 1163-1168
173. Gorriz E., Carreira J.M., Reyes R., et al. Intramuscular low flow vascular malformations: treatment by means of direct percutaneous embolization. Eur J Radiol 27 2 (1998) 161-165
174. Kuhne D., and Helmke K. Embolization with Ethibloc of vascular tumors and arteriovenous malformations in the head and neck. Neuroradiology 23 5 (1982) 253-258
175. Riche M.C., Hadjean E., Tran-Ba-Huy P., et al. The treatment of capillary-venous malformations using a new fibrosing agent. Plast Reconstr Surg 71 5 (1983) 607-614
176. Dubois J., Garel L., Abela A., et al. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 204 3 (1997) 651-654
177. Herbreteau D., Riche M.C., Enjolras O., et al. Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients. Int Angiol 12 1 (1993) 34-39
178. Coetzee PF, Ionescu GO, Fourie P, et al. Results of intralesional bleomycin injection treatment for congenital vascular anomalies. Paper presented at: 15th Congress of the International Society for the Study of Vascular Anomalies. Wellington, New Zealand, February 22-25, 2004.
179. Garcia-Marin V., Ravina J., Trujillo E., et al. Symptomatic cavernous hemangioma of the occipital condyle treated with methacrylate embolization. Surg Neurol 56 5 (2001) 301-303
180. Donnelly L.F., Bissett III G.S., and Adams D.M. Combined sonographic and fluoroscopic guidance: a modified technique for percutaneous sclerosis of low-flow vascular malformations. AJR Am J Roentgenol 173 3 (1999) 655-657
181. Donnelly L.F., Bisset III G.S., and Adams D.M. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect. Pediatr Radiol 30 6 (2000) 415-419
182. Holt P.D., and Burrows P.E. Interventional radiology in the treatment of vascular lesions. Facial Plast Surg Clin North Am 9 4 (2001) 585-599
183. Suh J.S., Shin K.H., Na J.B., et al. Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol. Cardiovasc Intervent Radiol 20 4 (1997) 268-273
184. Rosenberg L.Z. Sclerotherapy. emedicine.com. Available at: (2006). http://www.emedicine.com/plastic/topic437.htm Accessed February 3, 2008
185. Feied C.F., Jackson J.J., Bren T.S., et al. Allergic reactions to polidocanol for vein sclerosis: two case reports. J Dermatol Surg Oncol 20 7 (1994) 466-468
186. Deveikis J.P. Percutaneous ethanol sclerotherapy for vascular malformations in the head and neck. Arch Facial Plast Surg 7 5 (2005) 322-325
187. Wysoki M.G., and White Jr. R.I. Crystallization when mixing contrast materials with ethanol for embolization of venous malformations. J Vasc Interv Radiol 12 2 (2001) 264
188. Orbach E.J. Sclerotherapy of varicose veins: utilization of intravenous air block. Am J Surg 66 3 (1944) 362-366
189. Cabrera J., and Cabrera Jr. J. Nuevo método de esclerosis en las varices tronculares. Patol Vasc 4 (1995) 55-73
190. Cabrera J., Cabrera Jr. J., Garcia-Olmedo M.A., et al. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants. Phlebologie 2 (1997) 181-188
191. Tessari L. Nouvelle technique d'obtention de la sclero-mousse. Phlebologie 53 (2000) 129-133
192. Frullini A., and Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 28 1 (2002) 11-15
193. Hamel-Desnos C., Desnos P., Wollmann J.C., et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 29 12 (2003) 1170-1175 [discussion: 1175]
194. Puig S., Aref H., and Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications. AJR Am J Roentgenol 180 5 (2003) 1399-1401
195. Lee C.H., and Chen S.G. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plast Surg 58 8 (2005) 1073-1078
196. Beebe H.G., Bergan J.J., Bergqvist D., et al. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. Eur J Vasc Endovasc Surg 12 4 (1996) 487-491 [discussion: 491-82]
197. Noel A.A., Gloviczki P., Cherry Jr. K.J., et al. Surgical treatment of venous malformations in Klippel-Trenaunay syndrome. J Vasc Surg 32 5 (2000) 840-847
198. Bergan J., Pascarella L., and Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg (Torino) 47 1 (2006) 9-18
199. Mounayer C., Wassef M., Enjolras O., et al. Facial glomangiomas: large facial venous malformations with glomus cells. J Am Acad Dermatol 45 2 (2001) 239-245